International Journal of Clinical Research

Objective To explore the efficacy and value of using ambroxol hydrochloride in the clinical treatment of elderly pneumonia patients. Methods Sixty elderly patients with pneumonia who underwent treatment in a hospital from July 2022 to July 2023 were selected and divided into a control group (conventional treatment) and an observation group (ambroxol hydrochloride treatment), with 30 cases in each group, according to their treatment methods. The clinical efficacy of the two groups was compared. Results There was no statistically significant difference in oxygenation index and D-dimer index between the two groups before treatment (P<0.05). After treatment, the oxygenation index and lung function indicators of the observation group were higher than those of the control group, while the levels of D-dimer and inflammatory factors were lower than those of the control group. In addition, the treatment time and clinical symptom disappearance time of the observation group were shorter than those of the control group, and the differences were statistically significant (P<0.05). Conclusion Ambroxol hydrochloride has application value in elderly patients with pneumonia, which can help improve oxygenation, D-D, and lung function, reduce inflammation, accelerate clinical symptom disappearance, and promote recovery.

Elderly pneumonia; Ambroxol hydrochloride; Treatment effects